- Home
- RNAC vs FUBO Comparison
RNAC vs FUBO Comparison
Compare RNAC & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAC | FUBO |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 265.1M |
| IPO Year | 2016 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RNAC | FUBO |
|---|---|---|
| Price | $7.62 | $9.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $34.00 | $20.33 |
| AVG Volume (30 Days) | 94.2K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,797,000.00 | ★ $4,271,000.00 |
| Revenue This Year | N/A | $44.64 |
| Revenue Next Year | N/A | $5.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10317.07 |
| 52 Week Low | $5.60 | $1.02 |
| 52 Week High | $11.00 | $14.54 |
Technical Indicators
Market Signals| Indicator | RNAC | FUBO |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 41.51 |
| Support Level | $5.88 | $9.09 |
| Resistance Level | $8.39 | $10.79 |
| Average True Range (ATR) | 0.42 | 0.61 |
| MACD | -0.08 | -0.21 |
| Stochastic Oscillator | 12.65 | 1.47 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, Pay TV replacement product offering subscribers access to tens of thousands of live sporting events annually, alongside news and entertainment content, both live and on demand. Its platform is designed to empower customers to seamlessly access content through streaming devices and on Smart TVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features, including additional content or enhanced functionality suited to their preferences. Its subscription packages (including Fubo Essential, Pro, Elite, and others) boast a broad mix of top Nielsen-ranked channels across sports, news, and entertainment. The company operates in a single segment of the streaming business.